论文部分内容阅读
急性左心衰竭是急性心肌梗塞(AMI)的重要而又危险的并发症。在 AMI 治疗过程中,早期识别和及时处理急性左心衰竭,可显著降低心肌梗塞的死亡率.AMI 合并左心衰竭,与慢性心力衰竭相比,在病理生理方面有许多相似之处,也有一些不同的地力。本文简述 AMI 合并左心衰竭治疗的进展。一、洋地黄类药物再评价过去一般认为,在 AMI 24小时内不使用洋地黄类药物。目前主张对急性心衰采取较积极措施。许多作者认为,在严重急性左心衰发作时,快速洋地黄制剂仍有使用指征。一组 MI 合并心衰病人,
Acute left heart failure is an important and dangerous complication of acute myocardial infarction (AMI). In the course of AMI treatment, early identification and timely treatment of acute left heart failure can significantly reduce the mortality of myocardial infarction.AMI combined with left heart failure, compared with chronic heart failure, there are many similarities in the pathophysiology, there are some Different ground force. This article describes the progress of treatment of AMI combined with left heart failure. First, the digitalis drug reevaluation In the past generally believed that in the AMI 24 hours without digitalis drugs. Currently advocated more active measures for acute heart failure. Many authors believe that there is still indications for the use of digitalis preparations in the setting of severe acute left heart failure. A group of MI patients with heart failure,